UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Sepsis biomarkers.
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Journal Article
  • Authors:
    Prucha M, Bellingan G, Zazula R
  • Publication date:
    02/02/2015
  • Pagination:
    97, 103
  • Journal:
    Clin Chim Acta
  • Volume:
    440
  • Status:
    Published
  • Country:
    Netherlands
  • PII:
    S0009-8981(14)00504-X
  • Language:
    eng
  • Keywords:
    Biomarkers, SIRS, Sensitivity, Sepsis, Specificity, Acute-Phase Proteins, Biomarkers, C-Reactive Protein, Calcitonin, Carrier Proteins, Cytokines, Fibrin Fibrinogen Degradation Products, Humans, Intensive Care Units, Leukocytes, Lipopolysaccharide Receptors, Membrane Glycoproteins, Peptide Fragments, Protein Precursors, Sepsis, Systemic Inflammatory Response Syndrome
Abstract
Sepsis is the most frequent cause of death in non-coronary intensive care units (ICUs). In the past 10 years, progress has been made in the early identification of septic patients and in their treatment and these improvements in support and therapy mean that the mortality is gradually decreasing but it still remains unacceptably high. Leaving clinical diagnosis aside, the laboratory diagnostics represent a complex range of investigations that can place significant demands on the system given the speed of response required. There are hundreds of biomarkers which could be potentially used for diagnosis and prognosis in septic patients. The main attributes of successful markers would be high sensitivity, specificity, possibility of bed-side monitoring, and financial accessibility. Only a fraction is used in routine clinical practice because many lack sufficient sensitivity or specificity. The following review gives a short overview of the current epidemiology of sepsis, its pathogenesis and state-of-the-art knowledge on the use of specific biochemical, hematological and immunological parameters in its diagnostics. Prospective approaches towards discovery of new diagnostic biomarkers have been shortly mentioned.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Author
Experimental & Translational Medicine
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by